[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345262-105":59,"doc-detail-345262-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","inflammation-and-rons-dysregulation-by-redox-enzymes-as-mechanistic-links-in-hiv-1-cancer-comorbidity-review","Inflammation and RONS Dysregulation by Redox Enzymes as Mechanistic Links in HIV-1-Cancer Comorbidity - Review","","Antiretroviral therapy controls HIV-1 infection, yet people with HIV-1 (PWH) develop lifestyle- and age-related diseases, including cancers with higher incidence and mortality than those seen without HIV-1. A review highlights redox enzyme dysregulation as a mechanistic bridge between chronic HIV-1 and cancer comorbidity, shaping reactive oxygen/nitrogen species (RONS) management, inflammation, immune signaling, and mitochondrial function. Persistent HIV-1 elevates RONS and adaptive neutralization, sustaining an environment that supports tumor growth and therapy resistance. It summarizes effects on redox enzymes, current modulation strategies, and future co-treatment concepts.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/inflammation-and-rons-dysregulation-by-redox-enzymes-as-mechanistic-links-in-hiv-1-cancer-comorbidity-review/345262/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/inflammation-and-rons-dysregulation-by-redox-enzymes-as-mechanistic-links-in-hiv-1-cancer-comorbidity-review/345262.png","ImageObject",300,407,{"name":92,"@type":93},"Liam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does redox enzyme dysregulation play in HIV-1 and cancer comorbidity?","Question",{"text":112,"@type":113},"It links chronic HIV-1 infection and cancer by altering RONS management, inflammation, immune function, and mitochondrial function, creating conditions that can support tumor development and progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does chronic HIV-1 infection affect RONS levels and outcomes for tumors?",{"text":117,"@type":113},"Chronic HIV-1 increases both RONS production and RONS neutralization responses, maintaining a sustained RONS-rich environment that is dampened enough to avoid outright cytotoxicity while still promoting tumor proliferation and therapy resistance.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the review examine regarding therapeutic approaches?",{"text":121,"@type":113},"It reviews effects of chronic HIV-1 on redox enzyme function, discusses current methods to modulate redox activity, considers potential impacts on both HIV-1 infection and cancer progression, and proposes directions for future co-treatment.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345262,1790761058,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Review  \nInflammation and RONS Dysregulation by Redox Enzymes as Mechanistic Links in HIV-1–Cancer Comorbidity  \nCharles Gotuaco Ang 1, *, Shreya Eyunni 1,2 and Irwin M. Chaiken 1, *  \nAcademic Editor: Thibault Mesplède  \nReceived: 28 February 2026  \nRevised: 10 April 2026  \nAccepted: 10 April 2026  \nPublished: 14 April 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Biochemistry and Molecular Biology, College of Medicine, Drexel University, Philadelphia, PA 19102, USA; [se528@drexel.edu](se528@drexel.edu)  \n2 College of Arts and Sciences, Drexel University, Philadelphia, PA 19104, USA  \n* Correspondence: [gotuaco.ang@gmail.com](gotuaco.ang@gmail.com) (C.G.A.); [imc23@drexel.edu](imc23@drexel.edu) (I.M.C.)  \nAbstract  \nAntiretroviral therapy (ART) effectively controls Human Immunodeficiency Virus Type-1 (HIV-1) infection in people with HIV-1 (PWH), preventing the progression of their infections to AIDS. However, as PWH age, they experience lifestyle-and age-related diseases, notably various types of cancer beyond those traditionally associated with AIDS, with greater incidence and mortality than their non-HIV-1-positive counterparts, despite effective arrest of HIV-1 infection by ART. Dysregulation of redox enzymes presents an underexplored linkage between HIV-1 infection and cancer comorbidity, impacting reactive oxygen/nitrogen species (RONS) management, inflammation, immune function, and mitochondrial function. Chronic HIV-1 infection increases both RONS production and RONS neutralization responses, accelerating development of a sustained RONS-rich environment that still possesses sufficient dampening to prevent outright cytotoxic effects. Such an environment promotes both tumor proliferation and resistance adaptations to chemoand radiotherapies. This review considers the effects of chronic HIV-1 infection on redox enzyme function and links these effects to tumorigenic mechanisms as potentially shared pathways. We then examine current methods of modulating redox function, consider how these could potentially impact both HIV-1 infection and cancer progression, and lastly propose future methods of co-treatment that could be explored.  \nKeywords: cancer; comorbidity; disulfides; HIV-1; Protein Disulfide Isomerase; redox; reactive oxygen/nitrogen species; thiols; thioredoxin  \n1. Introduction: Cancer in People with HIV-1  \nComorbidities are a frequent (weighted average 33.4%) complication in people with cancer, with major impacts on risk, screening, diagnosis, and treatment [1] . People with Human Immunodeficiency Virus Type 1 (HIV-1) (PWH) have increased cancer risk and poorer outcomes in several cancer types, thought to result from chronic inflammation and immunosuppression, despite effective control of HIV-1 infection progression by antiretroviral therapy (ART) [2–4] .  \nIn the context of PWH, types of cancer can be described as “AIDS-defining cancers”(ADCs) or “non-AIDS-defining cancers”(NADCs), where the former are mechanistically linked to immunodeficiencies engendered by HIV-1 infection, but the latter are not [5,6] . Typical ADCs include Kaposi sarcoma, aggressive B-cell non-Hodgkin lymphomas, and cervical cancer; diagnosis with an ADC is largely synonymous with progression of HIV-1 infection to AIDS [7] . NADCs include more typical age-and lifestyle-related cancers, such  \nas cancers of the lung, breast, anus, skin, liver, and Hodgkin lymphomas [7,8] . Notably, ADC rates in PWH have fallen with the emergence and availability of effective ART, while NADC rates have continued to rise in PWH, even after extended use of ART [6,9] . Furthermore, population-based studies have demonstrated worse outcomes (increased morbidity and mortality) from NADCs in PWH than in people without HIV-1 [2–4,8–11] . Though the exact mechanisms driving enhanced NADC ","cbCaieO9AWAqaqLJ","https://ap.wps.com/l/cbCaieO9AWAqaqLJ","pdf",751695,21,"English","# Abstract\n# Introduction: Cancer in People with HIV-1\n## AIDS-defining vs non-AIDS-defining cancers\n## Redox enzyme mechanistic links: TXN1 and Protein Disulfide Isomerase","[{\"question\":\"What role does redox enzyme dysregulation play in HIV-1 and cancer comorbidity?\",\"answer\":\"It links chronic HIV-1 infection and cancer by altering RONS management, inflammation, immune function, and mitochondrial function, creating conditions that can support tumor development and progression.\"},{\"question\":\"How does chronic HIV-1 infection affect RONS levels and outcomes for tumors?\",\"answer\":\"Chronic HIV-1 increases both RONS production and RONS neutralization responses, maintaining a sustained RONS-rich environment that is dampened enough to avoid outright cytotoxicity while still promoting tumor proliferation and therapy resistance.\"},{\"question\":\"What does the review examine regarding therapeutic approaches?\",\"answer\":\"It reviews effects of chronic HIV-1 on redox enzyme function, discusses current methods to modulate redox activity, considers potential impacts on both HIV-1 infection and cancer progression, and proposes directions for future co-treatment.\"}]","Inflammation and RONS Dysregulation by Redox Enzymes as Mechanistic Links in HIV-1-Cancer Comorbidity - Review | PDF",1790056983,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e62ee584ea02d15f7e9abfb00ffd438.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/25923edf1a81d5f0d643257f6de34830.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b65196386fde7e43572b97d4bf92dc13.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c9a6121297679808ea2a300bbf13ab7e.webp",980,1385]